EMG
ASMB icon

Ellington Management Group’s Assembly Biosciences ASMB Stock Holding History

Ellington Management Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,292
Closed -$762K – 510
2018
Q1 		$762K Buy
+1,292
New +$801K 0.05% 282
2017
Q4 		– Sell
-617
Closed -$258K – 586
2017
Q3 		$258K Buy
+617
New +$189K 0.04% 444

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ellington Management Group's ASMB Position: Q2 2018 in Review

Ellington Management Group sold out of Assembly Biosciences (ASMB) in Q2 2018, closing a stake of 1,292 shares — an estimated $762K sold.

Ellington Management Group first reported a position in ASMB in Q3 2017 and held it in 2 quarters. The position peaked at $762K in Q1 2018. 105 funds tracked by Wall St. Rank hold ASMB as of Q2 2018.

  • Ellington Management Group reported no remaining Assembly Biosciences position as of Q2 2018 after selling out during the quarter.
  • Ellington Management Group sold 1,292 Assembly Biosciences shares in Q2 2018, an estimated $762K.
  • Ellington Management Group first reported a position in Assembly Biosciences in Q3 2017 and held it in 2 quarters.
  • Ellington Management Group's Assembly Biosciences position peaked at $762K in Q1 2018.
  • 105 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.